A Brazilian research team has eliminated HIV from a patient’s body for 78 consecutive weeks using only medications, without ...
Opportunistic infections target people with weakened immune systems, including those with HIV. These conditions can lead to ...
Despite effective HIV medication, the immune system of people with HIV remains disrupted in the long term.
The safety profile of the regimen was also found to be comparable to Biktarvy. ・Merck now intends to present findings from ...
Long-term, low doses of THC mitigate many harmful side effects and inflammation caused by HIV and antiretroviral therapy (ART ...
Despite effective HIV medication, the immune system of people with HIV remains disrupted in the long term. Researchers at ...
You can now be vaccinated against HIV – but that does not mean you can be reckless, warns the Department of Health ...
Merck reports positive results from phase 3 trial of once-daily, oral, two-drug, single-tablet regimen of Doravirine/Islatravir in treatment-naïve adults with HIV-1 infection ...
The KwaZulu-Natal Department of Health reports significant progress in HIV treatment outcomes, highlighting the achievements ...
To mark World AIDS Day, the Institute for Contemporary Arts will screen our film tackling the collapse of USAID funding ...
Texas Biomed researchers find that long-term, low doses of THC mitigate many harmful side effects and inflammation caused by HIV and antiretroviral therapy. The preclincial study shows promising ...